Literature DB >> 23076253

Characterization of tumor differentiation factor (TDF) and its receptor (TDF-R).

Izabela Sokolowska1, Alisa G Woods, Mary Ann Gawinowicz, Urmi Roy, Costel C Darie.   

Abstract

Tumor differentiation factor (TDF) is an under-investigated protein produced by the pituitary with no definitive function. TDF is secreted into the bloodstream and targets the breast and prostate, suggesting that it has an endocrine function. Initially, TDF was indirectly discovered based on the differentiation effect of alkaline pituitary extracts of the mammosomatotropic tumor MtTWlO on MTW9/PI rat mammary tumor cells. Years later, the cDNA clone responsible for this differentiation activity was isolated from a human pituitary cDNA library using expression cloning. The cDNA encoded a 108-amino-acid polypeptide that had differentiation activity on MCF7 breast cancer cells and on DU145 prostate cancer cells in vitro and in vivo. Recently, our group focused on identification of the TDF receptor (TDF-R). As potential TDF-R candidates, we identified the members of the Heat Shock 70-kDa family of proteins (HSP70) in both MCF7 and BT-549 human breast cancer cells (HBCC) and PC3, DU145, and LNCaP human prostate cancer cells (HPCC), but not in HeLa cells, NG108 neuroblastoma, or HDF-a and BLK CL.4 cells fibroblasts or fibroblast-like cells. Here we review the current advances on TDF, with particular focus on the structural investigation of its receptor and on its functional effects on breast and prostate cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23076253     DOI: 10.1007/s00018-012-1185-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  88 in total

Review 1.  Oestrogen receptors - an overview.

Authors:  E Enmark; J A Gustafsson
Journal:  J Intern Med       Date:  1999-08       Impact factor: 8.989

Review 2.  Estrogen receptor beta--a new dimension in estrogen mechanism of action.

Authors:  J A Gustafsson
Journal:  J Endocrinol       Date:  1999-12       Impact factor: 4.286

3.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.

Authors:  K Vleminckx; L Vakaet; M Mareel; W Fiers; F van Roy
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

Review 4.  Cell adhesion molecules: implications for a molecular histology.

Authors:  G M Edelman; K L Crossin
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

5.  Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions.

Authors:  P M Fernandez; S O Tabbara; L K Jacobs; F C Manning; T N Tsangaris; A M Schwartz; K A Kennedy; S R Patierno
Journal:  Breast Cancer Res Treat       Date:  2000-01       Impact factor: 4.872

Review 6.  Androgen receptor and prostate cancer.

Authors:  E Richter; S Srivastava; A Dobi
Journal:  Prostate Cancer Prostatic Dis       Date:  2007-02-13       Impact factor: 5.554

Review 7.  Androgen receptor involvement in the progression of prostate cancer.

Authors:  H Suzuki; T Ueda; T Ichikawa; H Ito
Journal:  Endocr Relat Cancer       Date:  2003-06       Impact factor: 5.678

8.  Association of the 90-kDa heat shock protein does not affect the ligand-binding ability of androgen receptor.

Authors:  T Nemoto; Y Ohara-Nemoto; M Ota
Journal:  J Steroid Biochem Mol Biol       Date:  1992-09       Impact factor: 4.292

9.  Structural characterization of fish egg vitelline envelope proteins by mass spectrometry.

Authors:  Costel C Darie; Martin L Biniossek; Luca Jovine; Eveline S Litscher; Paul M Wassarman
Journal:  Biochemistry       Date:  2004-06-15       Impact factor: 3.162

10.  Regulation of PERK signaling and leukemic cell survival by a novel cytosolic isoform of the UPR regulator GRP78/BiP.

Authors:  Min Ni; Hui Zhou; Shiuan Wey; Peter Baumeister; Amy S Lee
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

View more
  5 in total

Review 1.  Protein-protein interactions: switch from classical methods to proteomics and bioinformatics-based approaches.

Authors:  Armand G Ngounou Wetie; Izabela Sokolowska; Alisa G Woods; Urmi Roy; Katrin Deinhardt; Costel C Darie
Journal:  Cell Mol Life Sci       Date:  2013-04-12       Impact factor: 9.261

Review 2.  The potential of biomarkers in psychiatry: focus on proteomics.

Authors:  Izabela Sokolowska; Armand G Ngounou Wetie; Kelly Wormwood; Johannes Thome; Costel C Darie; Alisa G Woods
Journal:  J Neural Transm (Vienna)       Date:  2013-12-20       Impact factor: 3.575

3.  Structural evaluation and analyses of tumor differentiation factor.

Authors:  Urmi Roy; Alisa G Woods; Izabela Sokolowska; Costel C Darie
Journal:  Protein J       Date:  2013-10       Impact factor: 2.371

Review 4.  Mass spectrometry as a tool for studying autism spectrum disorder.

Authors:  Alisa G Woods; Armand G Ngounou Wetie; Izabela Sokolowska; Stefanie Russell; Jeanne P Ryan; Tanja Maria Michel; Johannes Thome; Costel C Darie
Journal:  J Mol Psychiatry       Date:  2013-05-21

Review 5.  Mass spectrometry for the detection of potential psychiatric biomarkers.

Authors:  Armand G Ngounou Wetie; Izabela Sokolowska; Kelly Wormwood; Katherine Beglinger; Tanja Maria Michel; Johannes Thome; Costel C Darie; Alisa G Woods
Journal:  J Mol Psychiatry       Date:  2013-06-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.